A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
GlaxoSmithKline
GlaxoSmithKline
Cook Group Incorporated
Cellestia Biotech AG
Celgene
Fate Therapeutics
Celgene
Incyte Corporation
Incyte Corporation
Shenzhen BinDeBio Ltd.
Mirna Therapeutics, Inc.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
INSYS Therapeutics Inc